[go: up one dir, main page]

RU2018120081A3 - - Google Patents

Download PDF

Info

Publication number
RU2018120081A3
RU2018120081A3 RU2018120081A RU2018120081A RU2018120081A3 RU 2018120081 A3 RU2018120081 A3 RU 2018120081A3 RU 2018120081 A RU2018120081 A RU 2018120081A RU 2018120081 A RU2018120081 A RU 2018120081A RU 2018120081 A3 RU2018120081 A3 RU 2018120081A3
Authority
RU
Russia
Application number
RU2018120081A
Other versions
RU2763404C2 (ru
RU2018120081A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2018120081A publication Critical patent/RU2018120081A/ru
Publication of RU2018120081A3 publication Critical patent/RU2018120081A3/ru
Application granted granted Critical
Publication of RU2763404C2 publication Critical patent/RU2763404C2/ru

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/775Apolipopeptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders
    • G01N2800/2821Alzheimer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders
    • G01N2800/2828Prion diseases
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2835Movement disorders, e.g. Parkinson, Huntington, Tourette
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Ecology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
RU2018120081A 2015-11-02 2016-11-02 Способы детекции аполипопротеинов RU2763404C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15382537.7A EP3163303A1 (en) 2015-11-02 2015-11-02 Methods for apolipoprotein detection
EP15382537.7 2015-11-02
PCT/EP2016/076457 WO2017076919A2 (en) 2015-11-02 2016-11-02 Methods for apolipoprotein detection

Publications (3)

Publication Number Publication Date
RU2018120081A RU2018120081A (ru) 2019-12-05
RU2018120081A3 true RU2018120081A3 (ru) 2020-03-10
RU2763404C2 RU2763404C2 (ru) 2021-12-28

Family

ID=54608470

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018120081A RU2763404C2 (ru) 2015-11-02 2016-11-02 Способы детекции аполипопротеинов

Country Status (16)

Country Link
US (1) US20180313854A1 (ru)
EP (3) EP3163303A1 (ru)
JP (1) JP6994718B2 (ru)
KR (1) KR102630558B1 (ru)
CN (2) CN119199154A (ru)
AU (1) AU2016348558B2 (ru)
CA (1) CA3003837A1 (ru)
DK (1) DK3274725T3 (ru)
ES (1) ES2728268T3 (ru)
HU (1) HUE042606T2 (ru)
MX (1) MX382446B (ru)
PL (1) PL3274725T3 (ru)
PT (1) PT3274725T (ru)
RU (1) RU2763404C2 (ru)
TR (1) TR201904846T4 (ru)
WO (1) WO2017076919A2 (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110234998A (zh) * 2016-07-21 2019-09-13 克利夫兰心脏实验室公司 Hdl相关蛋白质生物标记物组的检测
US20190369113A1 (en) 2018-06-01 2019-12-05 Laboratory Corporation Of America Holdings Simplified Biosample Processing for LC-MS/MS
CN109212218A (zh) * 2018-11-07 2019-01-15 李玉民 基于apoa4蛋白胃癌检测试剂盒、及其使用方法
WO2021050880A2 (en) * 2019-09-13 2021-03-18 Northwestern University Biomarkers for amyotrophic lateral sclerosis (als) and motor neuron diseases
CN110780071A (zh) * 2019-11-11 2020-02-11 彭涛 一种乙肝相关肝细胞癌的预后检测试剂盒
CN112375138B (zh) * 2020-11-13 2022-12-13 中元汇吉生物技术股份有限公司 一种重组载脂蛋白e和应用
CN115541568B (zh) * 2021-06-29 2025-07-11 厦门红观生物科技有限公司 一种泪液试纸上ApoJ提取和定量检测方法及其试剂盒和应用
CN117886933A (zh) * 2023-12-28 2024-04-16 上海良润生物医药科技有限公司 一种载脂蛋白e检测试剂及其应用
WO2025219956A1 (en) * 2024-04-18 2025-10-23 Comed Therapeutics Ltd. Compositions and methods for rna delivery to cells

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772549A (en) * 1986-05-30 1988-09-20 Biotechnology Research Partners, Ltd. Polymorphisms related to lipid metabolism: ApoB, ApoCII, ApoE, ApoAIV
US5945289A (en) 1996-12-20 1999-08-31 Lehrer; Steven Method for detecting prostate cancer by apolipoprotein E (Apo-E) genotyping
JP3397066B2 (ja) * 1996-12-27 2003-04-14 富士レビオ株式会社 免疫学的測定方法を用いたアポ蛋白eフェノタイプの同定方法
AU762931B2 (en) * 1999-03-16 2003-07-10 Serex, Inc. Method and device for detection of Apo A, Apo B and the ratio thereof in saliva
JP4153873B2 (ja) * 2001-10-04 2008-09-24 株式会社 免疫生物研究所 アルツハイマー危険因子の検出試薬および検出用キットならびにこれらを用いるアルツハイマー危険因子の検出方法
EP1482897A2 (en) * 2002-02-19 2004-12-08 Ilex Products, Inc. Aminodiphosphonate apolipoprotein e modulators
WO2005072152A2 (en) * 2004-01-22 2005-08-11 Genaissance Pharmaceuticals, Inc. Apoc1 genetic markers associated with age of onset of alzheimer's disease
JP5229789B2 (ja) * 2007-02-27 2013-07-03 プリマハム株式会社 新規ストレスバイオマーカー及びその用途
WO2009108073A1 (en) * 2008-02-28 2009-09-03 Auckland Uniservices Limited Biomarkers for prediction of preeclampsia and/or cardiovascular disease
ES2364169B1 (es) * 2010-02-09 2012-07-10 CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) (Titular al 50%) Uso de las isoformas de apo j como biomarcadores de lesión tisular.
CA2791648A1 (en) * 2010-03-01 2011-09-09 The J. David Gladstone Institutes Antibody specific for apolipoprotein and methods of use thereof
US20120009125A1 (en) * 2010-07-06 2012-01-12 Lombard Jay L Apoe4 and apoj biomarker-based prevention and treatment of dementia
WO2013170057A2 (en) * 2012-05-09 2013-11-14 President And Fellows Of Harvard College Quantification of lipoproteins
ES2759026T3 (es) * 2013-02-26 2020-05-07 Inst Oftalmologico Fernandez Vega S L Método para el diagnóstico de glaucoma basándose en la determinación de niveles de proteínas séricas

Also Published As

Publication number Publication date
DK3274725T3 (en) 2019-04-23
TR201904846T4 (tr) 2019-04-22
EP3274725A2 (en) 2018-01-31
CN119199154A (zh) 2024-12-27
MX2018005448A (es) 2019-04-04
PL3274725T3 (pl) 2019-08-30
PT3274725T (pt) 2019-04-30
AU2016348558A1 (en) 2018-06-21
CN108700593A (zh) 2018-10-23
ES2728268T3 (es) 2019-10-23
JP6994718B2 (ja) 2022-01-14
EP3457140A1 (en) 2019-03-20
BR112018008749A8 (pt) 2019-02-26
MX382446B (es) 2025-03-13
RU2763404C2 (ru) 2021-12-28
KR20180081545A (ko) 2018-07-16
RU2018120081A (ru) 2019-12-05
EP3274725B1 (en) 2019-01-09
US20180313854A1 (en) 2018-11-01
JP2018533022A (ja) 2018-11-08
HUE042606T2 (hu) 2019-07-29
WO2017076919A2 (en) 2017-05-11
KR102630558B1 (ko) 2024-01-26
AU2016348558B2 (en) 2022-02-24
EP3163303A1 (en) 2017-05-03
CA3003837A1 (en) 2017-05-11
WO2017076919A3 (en) 2017-06-15
BR112018008749A2 (pt) 2018-10-30

Similar Documents

Publication Publication Date Title
BR112016003711A2 (ru)
BR112018005703A2 (ru)
BR112018004758A2 (ru)
RU2018120081A3 (ru)
BR112018004773A2 (ru)
BR0006634B1 (ru)
BR0007487B1 (ru)
BR0009373B1 (ru)
BR0009349B1 (ru)
BR0009182B1 (ru)
BR0008874B1 (ru)
BR0008789B1 (ru)
BR0008719B1 (ru)
BR0008604B1 (ru)
BR0008158B1 (ru)
BR0008132B1 (ru)
BR0007834B1 (ru)
BR0007747B1 (ru)
BR0003751B1 (ru)
BR0007672B1 (ru)
BR0003928B1 (ru)
BR0007468B1 (ru)
BR0006866B1 (ru)
BR0006854B1 (ru)
BR0002874B1 (ru)